Hepatitis C in Arkansas: updates on epidemiology, testing and treatment

Insights

Hepatitis C virus (HCV) infection is a common blood-borne illness. Arkansas is profiling HCV infection and screening at-risk populations to improve awareness and connect patients to care.

Area of Science:

  • Epidemiology
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is the most common blood-borne infection in the US, affecting an estimated 2.7 million people.
  • Chronic HCV infection, developing in 75-85% of cases, can lead to severe liver diseases like cirrhosis and hepatocellular carcinoma over many years.
  • Identifying infected individuals and ensuring access to affordable treatment and care are critical public health priorities.

Purpose of the Study:

  • To examine the epidemiologic burden of Hepatitis C virus infection within Arkansas.
  • To increase awareness of Hepatitis C infection among Arkansans.
  • To connect at-risk individuals with Hepatitis C testing and care.

Main Methods:

  • The Arkansas Department of Health developed an epidemiologic profile using 2013 data.
  • Data sources included the department's Hepatitis C surveillance program.
  • Local health units initiated screening for individuals born between 1945-1965.

Main Results:

  • An epidemiologic profile of Hepatitis C virus infection in Arkansas was created.
  • Screening efforts were expanded to all 75 counties, targeting at-risk populations.
  • The initiative aims to improve identification and linkage to care for Hepatitis C patients.

Conclusions:

  • Identifying Hepatitis C virus infection and linking patients to affordable treatment remain key objectives.
  • Public health initiatives are crucial for managing the burden of Hepatitis C.
  • Targeted screening programs are essential for early detection and intervention.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
59
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
922
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
263